Koers Cell MedX Corp. Other OTC
Aandelen
CMXC
US15115X1072
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 0,01 0,01 | Omzet 2023 | 0 0 | Marktkapitalisatie | 6,29K 5,8K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 1.135.153.669 x |
Nettoschuld 2022 | 592K 546K | Nettoschuld 2023 | 903K 831K | EV/omzet 2023 | 329.116.944 x |
K/w-verhouding 2022 |
-9,01
x | K/w-verhouding 2023 |
-0,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 20,34% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24-11-14 |
George Adams
CHM | Chairman | 76 | 23-03-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27-04-22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08-06-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 50,93 mld. | |
-0,09% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-4,96% | 29,18 mld. | |
+11,18% | 26,02 mld. | |
-21,95% | 18,9 mld. | |
+8,61% | 13,21 mld. | |
+24,73% | 12,17 mld. | |
+28,31% | 12,16 mld. |